The proposal follows several other efforts to combat the ongoing epidemic on both the state and federal levels—some more effective than others.
Officials in Nebraska used fentanyl to execute a death row inmate on Tuesday, marking the first time the powerful opioid has been used to carry out the death penalty in the United States.
In only the second-ever case of its kind, a pharmaceutical company sued Wednesday to stop the state of Nevada from using an untested drug in a lethal injection.
Even our most personal health conditions are part of a vast but hidden market for our medical data. Don't we deserve to know about it?
An early look at a Pacific Standard story that's currently only available to subscribers.
Researchers at the University of Toronto filed the first patent for insulin therapy 92 years ago. Today, there's still no lower-cost generic.
According to United States law, studies of potential medicines and diagnostics are supposed to make their results publicly available within 12 months. But up to half of studies don’t follow the rules—and no one has ever faced penalties.
A comprehensive analysis of drug company spending on doctors in the last five months of 2013 shows the most-promoted products typically were not cures, breakthroughs, or top sellers.
Nearly every large drug maker based in the United States had at least one academic medical center official on its board, raising questions about their independence.